Why this grouping
MONDO alignment & provenance
The grouping concept corresponds to the MONDO glycoprotein storage disease class. closeMatch rather than exactMatch because the Disease entry Glycoprotein_Storage_Disease already carries MONDO:0009296 as its exact disease_term, and the member list here (which includes galactosialidosis and the three NAGA deficiency forms) has not been audited against MONDO's descendant closure.
Membership criteria
- OR
The causal locus is one of the glycoproteinosis genes.
- HAS GENE
FUCA1 hgnc:4006
Deficiency of lysosomal alpha-L-fucosidase (FUCA1).
- HAS GENE
MAN2B1 hgnc:6826
Deficiency of lysosomal alpha-mannosidase (MAN2B1).
- HAS GENE
MANBA hgnc:6831
Deficiency of lysosomal beta-mannosidase (MANBA).
- HAS GENE
AGA hgnc:318
Deficiency of aspartylglucosaminidase (AGA).
- HAS GENE
NEU1 hgnc:7758
Deficiency of lysosomal neuraminidase 1 (NEU1).
- HAS GENE
CTSA hgnc:9251
Deficiency of protective protein/cathepsin A (CTSA), with secondary loss of NEU1 and beta-galactosidase.
- HAS GENE
NAGA hgnc:7631
Deficiency of alpha-N-acetylgalactosaminidase (NAGA).
- HAS GENE
FUCA1 hgnc:4006
Coverage and gaps
No exact MONDO mapping is declared, so MONDO descendant gaps are not inferred for this grouping.
| Status | DisMech entry | MONDO concept | In DisMech | Has MONDO ID | In grouping MONDO | Member state | Conditions satisfied | C1.1 Deficiency of lysosomal alpha-L-fucosidase (FUCA1). hgnc:4006 | C1.2 Deficiency of lysosomal alpha-mannosidase (MAN2B1). hgnc:6826 | C1.3 Deficiency of lysosomal beta-mannosidase (MANBA). hgnc:6831 | C1.4 Deficiency of aspartylglucosaminidase (AGA). hgnc:318 | C1.5 Deficiency of lysosomal neuraminidase 1 (NEU1). hgnc:7758 | C1.6 Deficiency of protective protein/cathepsin A (CTSA), with secondary loss of NEU1 and beta-galactosidase. hgnc:9251 | C1.7 Deficiency of alpha-N-acetylgalactosaminidase (NAGA). hgnc:7631 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| listed with MONDO ID |
Schindler Disease
DISEASE
Differentiating mechanismAlpha-N-acetylgalactosaminidase (NAGA) deficiency in its severe infantile neuroaxonal dystrophy form (type 1).
NAGA hgnc:7631
|
alpha-N-acetylgalactosaminidase deficiency type 1
MONDO:0012221
|
yes | yes | not assessed | listed | satisfied | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED |
| listed with MONDO ID |
Kanzaki Disease
DISEASE
Differentiating mechanismNAGA deficiency in the adult-onset form (type 2) with angiokeratoma corporis diffusum and milder neurological involvement.
NAGA hgnc:7631
|
alpha-N-acetylgalactosaminidase deficiency type 2
MONDO:0012222
|
yes | yes | not assessed | listed | satisfied | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED |
| listed with MONDO ID |
NAGA Deficiency Type 3
DISEASE
Differentiating mechanismNAGA deficiency in the intermediate form (type 3), with variable neurological and psychiatric presentation.
NAGA hgnc:7631
|
alpha-N-acetylgalactosaminidase deficiency type 3
MONDO:0019264
|
yes | yes | not assessed | listed | satisfied | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED |
| listed with MONDO ID |
Alpha-mannosidosis
DISEASE
Differentiating mechanismLysosomal alpha-mannosidase (MAN2B1) deficiency stores mannose-rich oligosaccharides; intellectual disability, hearing loss and immunodeficiency with recurrent infection are distinguishing.
MAN2B1 hgnc:6826
|
alpha-mannosidosis
MONDO:0009561
|
yes | yes | not assessed | listed | satisfied | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED |
| listed with MONDO ID |
Aspartylglucosaminuria
DISEASE
Differentiating mechanismAspartylglucosaminidase (AGA) deficiency blocks cleavage of the asparagine-GlcNAc linkage, the final step of N-glycoprotein degradation, storing aspartylglucosamine; slowly progressive intellectual decline, Finnish-enriched.
AGA hgnc:318
|
aspartylglucosaminuria
MONDO:0008830
|
yes | yes | not assessed | listed | satisfied | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED |
| listed with MONDO ID |
Beta Mannosidosis
DISEASE
Differentiating mechanismLysosomal beta-mannosidase (MANBA) deficiency blocks removal of the core beta-linked mannose, storing a disaccharide; usually a milder, variable phenotype dominated by intellectual disability and hearing loss.
MANBA hgnc:6831
|
beta-mannosidosis
MONDO:0009562
|
yes | yes | not assessed | listed | satisfied | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED |
| listed with MONDO ID |
Congenital Sialidosis Type 2
DISEASE
Differentiating mechanismProfound NEU1 deficiency in the congenital (type 2) form, presenting with nonimmune hydrops fetalis or neonatal ascites.
NEU1 hgnc:7758
|
congenital sialidosis type 2
MONDO:0019682
|
yes | yes | not assessed | listed | satisfied | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED |
| listed with MONDO ID |
Fucosidosis
DISEASE
Differentiating mechanismAlpha-L-fucosidase (FUCA1) deficiency stores fucose-containing glycoproteins, glycolipids and oligosaccharides; progressive neurodegeneration with angiokeratoma in longer-surviving patients.
FUCA1 hgnc:4006
|
fucosidosis
MONDO:0009254
|
yes | yes | not assessed | listed | satisfied | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED |
| listed with MONDO ID |
Galactosialidosis
DISEASE
Differentiating mechanismLoss of the protective protein/cathepsin A (CTSA) destabilizes the lysosomal multienzyme complex, causing combined secondary deficiency of NEU1 and beta-galactosidase; sialidosis-like storage with a protein-stabilization rather than glycosidase-gene lesion.
CTSA hgnc:9251
|
galactosialidosis
MONDO:0009737
|
yes | yes | not assessed | listed | satisfied | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED |
| listed with MONDO ID |
Juvenile Sialidosis Type 2
DISEASE
Differentiating mechanismNEU1 deficiency in the childhood-onset dysmorphic (type 2) form, with coarse facies, dysostosis multiplex and progressive neurological impairment.
NEU1 hgnc:7758
|
juvenile sialidosis type 2
MONDO:0019681
|
yes | yes | not assessed | listed | satisfied | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED |
| listed with MONDO ID |
Sialidosis type 1
DISEASE
Differentiating mechanismPartial neuraminidase 1 (NEU1) deficiency stores sialyloligosaccharides in the normosomatic, later-onset cherry-red spot myoclonus form, without dysmorphism or dysostosis.
NEU1 hgnc:7758
|
sialidosis type 1
MONDO:0019346
|
yes | yes | not assessed | listed | satisfied | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED |
Source
View YAML on GitHubRaw YAML
name: Glycoproteinoses
display_name: Glycoproteinoses (oligosaccharidoses)
creation_date: "2026-10-11T00:00:00Z"
description: >-
The glycoproteinoses (oligosaccharidoses, glycoprotein storage diseases) are
autosomal recessive lysosomal storage disorders in which a defect in the
stepwise lysosomal degradation of the N- and O-linked glycans of
glycoproteins causes accumulation of undegraded oligosaccharides and
glycopeptides, with urinary oligosaccharide or glycopeptide excretion and a
progressive multisystem, often neurodegenerative, phenotype. Each member is
caused by deficiency of a different lysosomal glycosidase or amidase, or, in
galactosialidosis, of the protective protein that stabilizes two of them.
grouping_basis:
- SHARED_MECHANISM
- CLINICAL_CONVENTION
grouping_rationale: >-
Grouped on a shared mechanism: every member is a failure of lysosomal
glycoprotein glycan catabolism, producing oligosaccharide/glycopeptide
storage. The members are kept as separate Disease entries because they differ
in the deficient enzyme and gene, the stored glycan species, and the clinical
course (for example the immune phenotype of alpha-mannosidosis, the
normosomatic myoclonus form of sialidosis type 1, the angiokeratoma of
Kanzaki disease). The class-level Disease entry Glycoprotein_Storage_Disease
(MONDO:0009296) models the shared final common pathway and is deliberately
not listed as a member, because it is the class itself rather than one of the
diseases it contains; this grouping is the explicit member union that entry
describes in prose.
mappings:
mondo_mappings:
- term:
id: MONDO:0009296
label: glycoprotein storage disease
mapping_predicate: skos:closeMatch
mapping_source: MONDO
mapping_justification: >-
The grouping concept corresponds to the MONDO glycoprotein storage disease
class. closeMatch rather than exactMatch because the Disease entry
Glycoprotein_Storage_Disease already carries MONDO:0009296 as its exact
disease_term, and the member list here (which includes galactosialidosis
and the three NAGA deficiency forms) has not been audited against MONDO's
descendant closure.
membership_criteria:
- description: >-
A disorder belongs to the glycoproteinoses only if its causal gene encodes a
lysosomal enzyme of glycoprotein glycan degradation (FUCA1, MAN2B1, MANBA,
AGA, NEU1, NAGA) or the protective protein CTSA that stabilizes NEU1 and
beta-galactosidase in the lysosome.
criteria_semantics: NECESSARY
logic:
operator: OR
description: The causal locus is one of the glycoproteinosis genes.
operands:
- criterion_predicate: HAS_GENE
description: Deficiency of lysosomal alpha-L-fucosidase (FUCA1).
gene:
preferred_term: FUCA1
term:
id: hgnc:4006
label: FUCA1
- criterion_predicate: HAS_GENE
description: Deficiency of lysosomal alpha-mannosidase (MAN2B1).
gene:
preferred_term: MAN2B1
term:
id: hgnc:6826
label: MAN2B1
- criterion_predicate: HAS_GENE
description: Deficiency of lysosomal beta-mannosidase (MANBA).
gene:
preferred_term: MANBA
term:
id: hgnc:6831
label: MANBA
- criterion_predicate: HAS_GENE
description: Deficiency of aspartylglucosaminidase (AGA).
gene:
preferred_term: AGA
term:
id: hgnc:318
label: AGA
- criterion_predicate: HAS_GENE
description: Deficiency of lysosomal neuraminidase 1 (NEU1).
gene:
preferred_term: NEU1
term:
id: hgnc:7758
label: NEU1
- criterion_predicate: HAS_GENE
description: Deficiency of protective protein/cathepsin A (CTSA), with secondary loss of NEU1 and beta-galactosidase.
gene:
preferred_term: CTSA
term:
id: hgnc:9251
label: CTSA
- criterion_predicate: HAS_GENE
description: Deficiency of alpha-N-acetylgalactosaminidase (NAGA).
gene:
preferred_term: NAGA
term:
id: hgnc:7631
label: NAGA
members:
- member: Fucosidosis
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Alpha-L-fucosidase (FUCA1) deficiency stores fucose-containing glycoproteins, glycolipids and oligosaccharides; progressive neurodegeneration with angiokeratoma in longer-surviving patients.
gene:
preferred_term: FUCA1
term:
id: hgnc:4006
label: FUCA1
- member: Alpha-mannosidosis
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Lysosomal alpha-mannosidase (MAN2B1) deficiency stores mannose-rich oligosaccharides; intellectual disability, hearing loss and immunodeficiency with recurrent infection are distinguishing.
gene:
preferred_term: MAN2B1
term:
id: hgnc:6826
label: MAN2B1
- member: Beta Mannosidosis
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Lysosomal beta-mannosidase (MANBA) deficiency blocks removal of the core beta-linked mannose, storing a disaccharide; usually a milder, variable phenotype dominated by intellectual disability and hearing loss.
gene:
preferred_term: MANBA
term:
id: hgnc:6831
label: MANBA
- member: Aspartylglucosaminuria
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Aspartylglucosaminidase (AGA) deficiency blocks cleavage of the asparagine-GlcNAc linkage, the final step of N-glycoprotein degradation, storing aspartylglucosamine; slowly progressive intellectual decline, Finnish-enriched.
gene:
preferred_term: AGA
term:
id: hgnc:318
label: AGA
- member: Sialidosis type 1
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Partial neuraminidase 1 (NEU1) deficiency stores sialyloligosaccharides in the normosomatic, later-onset cherry-red spot myoclonus form, without dysmorphism or dysostosis.
gene:
preferred_term: NEU1
term:
id: hgnc:7758
label: NEU1
- member: Juvenile Sialidosis Type 2
member_type: DISEASE
differentiating_mechanisms:
- description: >-
NEU1 deficiency in the childhood-onset dysmorphic (type 2) form, with coarse facies, dysostosis multiplex and progressive neurological impairment.
gene:
preferred_term: NEU1
term:
id: hgnc:7758
label: NEU1
- member: Congenital Sialidosis Type 2
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Profound NEU1 deficiency in the congenital (type 2) form, presenting with nonimmune hydrops fetalis or neonatal ascites.
gene:
preferred_term: NEU1
term:
id: hgnc:7758
label: NEU1
- member: Galactosialidosis
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Loss of the protective protein/cathepsin A (CTSA) destabilizes the lysosomal multienzyme complex, causing combined secondary deficiency of NEU1 and beta-galactosidase; sialidosis-like storage with a protein-stabilization rather than glycosidase-gene lesion.
gene:
preferred_term: CTSA
term:
id: hgnc:9251
label: CTSA
- member: Schindler Disease
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Alpha-N-acetylgalactosaminidase (NAGA) deficiency in its severe infantile neuroaxonal dystrophy form (type 1).
gene:
preferred_term: NAGA
term:
id: hgnc:7631
label: NAGA
- member: Kanzaki Disease
member_type: DISEASE
differentiating_mechanisms:
- description: >-
NAGA deficiency in the adult-onset form (type 2) with angiokeratoma corporis diffusum and milder neurological involvement.
gene:
preferred_term: NAGA
term:
id: hgnc:7631
label: NAGA
- member: NAGA Deficiency Type 3
member_type: DISEASE
differentiating_mechanisms:
- description: >-
NAGA deficiency in the intermediate form (type 3), with variable neurological and psychiatric presentation.
gene:
preferred_term: NAGA
term:
id: hgnc:7631
label: NAGA
notes: >-
Created as the explicit member union for the class-level Disease entry
Glycoprotein_Storage_Disease, which names these member disorders in its
description. Nine of the eleven members are also listed directly in
Lysosomal_Storage_Disorders; Fucosidosis and Beta Mannosidosis are not.
Nesting this grouping inside Lysosomal_Storage_Disorders (replacing its
direct oligosaccharidosis rows) is a decision for that grouping and has not
been made here.